Transcatheter Aortic Valve Replacement (TAVR) Market Growth Forecast at 18.3% CAGR to 2026 - Key Player Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, Inc.

Transcatheter Aortic Valve Replacement (TAVR) market size is estimated to grow at a CAGR of 18.3% during the forecast period.

Transcatheter aortic valve replacement (TAVR), known as transcatheter aortic valve implantation (TAVI) the surgical procedure for heart disease wherein transcatheter heart valve is used to replace the damaged as well as old heart valve. Transcatheter heart valve implantation is a minimally invasive process that helps in substituting the damaged heart valve with a prosthetic valve for treatment of mitral regurgitation and unembellished aortic stenosis. Transcatheter aortic valve replacement procedure that helps to diminish severe degenerative aortic stenosis and increases the survival rate of patients.

Sample copy of this report@ https://www.polarismarketresearch.com/industry-analysis/transcatheter-aortic-valve-replacement-tavr-market/request-for-free-sample

The global Transcatheter Aortic Valve Replacement (TAVR) Market is driven by factors such as growing number of the patient pool with cardiovascular ailments such as coronary artery diseases, heart failures, and hypertension. According to World Health Organization (WHO), the number of people suffering cardiovascular disorders will surge to 22.2 million by 2030 globally. Moreover, rising implementation of minimally intrusive processes over traditional surgical open-heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss is further propelling the market.

Transcatheter Aortic Valve Replacement (TAVR) Market key player are Boston Scientific Corporation, Direct Flow medical, Inc., Edwards Lifesciences Corporation, HLT, Inc., JenaValve Technology, Inc., Medtronic plc, Meril Life Sciences Pvt. Ltd., St. Jude Medical, Inc., SYMETIS SA, and Transcatheter Technologies GmbH among others.

The global transcatheter valve replacement (TAVR) market is segmented on the basis of surgical procedure, end user, and geography.

Transcatheter Aortic Valve Replacement (TAVR) Market On the basis of surgical procedure: the global transcatheter valve replacement (TAVR) market is categorized into Transfemoral (TF) Implantation, Transapical (TA) Implantation, and Transaortic Implantation. The global market by the surgical procedure is dominated by Transfemoral (TF) Implantation majorly due to growing focus on tentative products by key players which are estimated to boost the market growth of transcatheter valve replacement (TAVR) market globally. Moreover, Transfemoral implantation is the standardized as well as consistent TAVR procedure, in which an artificial valve is inserted through the femoral blood vessel with the minimally invasive procedure and negligible anesthesia. Thus, the transferomal (TF) implantation segment accounted for the highest market share in 2017 and is anticipated to preserve the governance during the forecast period.

Browse Complete Report Summary @ https://www.polarismarketresearch.com/industry-analysis/transcatheter-aortic-valve-replacement-tavr-market/

Transcatheter Aortic Valve Replacement (TAVR) Market On the basis of end users: the global transcatheter aortic valve replacement (TAVR) market is further categorized into hospitals, ambulatory surgical centers, and cardiac catheterization laboratory. The Hospital segment is expected to show the highest market growth over the forecast period. Growing patient pool and rising demand for efficient and effective surgical process with shorter recovery time and reduced hospital stay are the key factors driving the market shares for hospitals in global transcatheter aortic valve replacement (TAVR) market.

Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/transcatheter-aortic-valve-replacement-tavr-market/inquire-before-buying

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.